DUBLIN, Sep 01, 2010 (BUSINESS WIRE) —

Covidien (NYSE: COV), a leading global provider of healthcare
products, today announced the agenda for its investor meeting on
Wednesday, September 15, 2010. The event will be held at The Plaza
Hotel, Fifth Avenue at Central Park South, New York, NY. A webcast
of the presentations will begin at 12:00 pm and the webcast will
conclude by 5:00 pm.

The program will include presentations by Covidien’s Chairman,
President and CEO Richard J. Meelia and other members of the senior
management team, including the leaders of each of Covidien’s three
business segments. For those investors who are unable to attend the
meeting in person, but who would like to ask a question of the
management team during the meeting, questions can be emailed to 2010cov@gmail.com.

				Agenda
				10:00 am					Registration Opens
				10:15 am					Product Displays and Senior Management Reception
				12:00 pm					Presentations begin
									— Richard J. Meelia, Chairman, President and CEO
									— James C. Clemmer, President, Medical Supplies
									— Timothy R. Wright, President, Pharmaceuticals
									— José (Joe) E. Almeida, President, Medical Devices
									— Joseph Woody, President, Vascular Therapies
				4:00 pm					Charles J. Dockendorff, Chief Financial Officer
				5:00 pm					Presentations and webcast end

Advanced registration is required and attendance will be limited
to those who register in advance. To register for the meeting,
please go to the following website:
http://www.zoomerang.com/Survey/WEB22AVCGMQHWX

Individuals who are unable to attend the meeting in person will
be able to view a live video and webcast at Covidien’s website:
http://investor.covidien.com. A replay of the presentations and
the presentation materials will be available at the same website
following the conclusion of the meeting.

ABOUT COVIDIEN

Covidien is a leading global healthcare products company that
creates innovative medical solutions for better patient outcomes
and delivers value through clinical leadership and excellence.
Covidien manufactures, distributes and services a diverse range of
industry-leading product lines in three segments: Medical Devices,
Pharmaceuticals and Medical Supplies. With 2009 revenue of $10.3
billion, Covidien has 42,000 employees worldwide in more than 60
countries, and its products are sold in over 140 countries. Please
visit
www.covidien.com to learn more about our business.

SOURCE